In patients with PSA values ≤2.82 ng/ml at least one lesion characteristic of prostate cancer was identified in 68.8% of patients with 68Ga-PSMA-11 PET/CT, but only in 43.8% of patients with 18FEC PET/CT. This evidence concerns the gene KLK3 and prostate cancer.